AlphaGrep UK Ltd’s Cabot Corp CBT Stock Holding History

AlphaGrep UK Ltd’s Portfolio CBT Stock Details CBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-4,088	Closed	-$271K	–	798
2025 Q4	$271K	Buy	+4,088	New	+$272K	0.09%	484

Other funds holding CBT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

AlphaGrep UK Ltd's CBT Position: Q1 2026 in Review

AlphaGrep UK Ltd sold out of Cabot Corp (CBT) in Q1 2026, closing a stake of 4,088 shares — an estimated $271K sold.

AlphaGrep UK Ltd first reported a position in CBT in Q4 2025 and held it in 1 quarter. The position peaked at $271K in Q4 2025. 374 funds tracked by Wall St. Rank hold CBT as of Q1 2026.

AlphaGrep UK Ltd reported no remaining Cabot Corp position as of Q1 2026 after selling out during the quarter.
AlphaGrep UK Ltd sold 4,088 Cabot Corp shares in Q1 2026, an estimated $271K.
AlphaGrep UK Ltd first reported a position in Cabot Corp in Q4 2025 and held it in 1 quarter.
AlphaGrep UK Ltd's Cabot Corp position peaked at $271K in Q4 2025.
374 funds tracked by Wall St. Rank held Cabot Corp as of Q1 2026.

Based on AlphaGrep UK Ltd's 13F filing for Q1 2026, filed 13 Aug 2026.